Iterum Therapeutics Plc share price logo

Iterum Therapeutics Plc Share Price

NASDAQ: ITRM

Small Cap

$0.16

-0.01

(-4.04%)

as on

Iterum Therapeutics Plc Stock Performance

as on March 21, 2026 at 6:59 am IST

  • Day's High

    $0.16
    $0.17

    6.25%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.14
    $1.50
    downward going graph

    15.19%

    Downside

    837.50%

    Upside

    downward going graph

Iterum Therapeutics Plc share price movements today

Previous Close
$0.17
Open
$0.17
Volume
1.3M
Day's Low - High
$0.16 - $0.17
52 Week Low - High
$0.14 - $1.50

Iterum Therapeutics Plc Historical Returns

1 Month Return
-23.92 %
3 Month Return
-56.41 %
1 Year Return
-88.8 %
3 Year Return
-84.64 %
5 Year Return
-99.36 %

Iterum Therapeutics Plc Stock Fundamentals & Key Indicators

Check Iterum Therapeutics Plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.1M

EPS (TTM)

-0.66

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-19.3M

Revenue (TTM)

390.0K

Profit Margin

0.00%

Return On Equity TTM

-555.68%

Iterum Therapeutics Plc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Iterum Therapeutics Plc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Iterum Therapeutics Plc image
Iterum Therapeutics Plc
BUY$9.1M-99.36%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.3B116.54%133.528.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$116.3B110.08%29.9432.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.5BNA114.935.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.0B54.71%17.831.41%

Stock Returns calculator for Iterum Therapeutics Plc Stock including INR - Dollar returns

The Iterum Therapeutics Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Iterum Therapeutics Plc investment value today

Current value as on today

₹20,556

Returns

₹79,444

(-79.44%)

Returns from Iterum Therapeutics Plc Stock

₹88,889 (-88.89%)

Dollar Returns*

₹9,445 (+9.44%)

Analyst Recommendation on Iterum Therapeutics Plc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Iterum Therapeutics Plc. Average target price of $9

Iterum Therapeutics Plc Share Price Target

Get share price movements and forecasts by analysts on Iterum Therapeutics Plc.

What analysts predicted

98.22%UPSIDE

Target Price

$9

Current Price

$0.16

Analyzed by

8 Analysts

Target

$9.00

Iterum Therapeutics Plc target price $9, a slight upside of 98.22% compared to current price of $0.16. According to 8 analysts rating.

Iterum Therapeutics Plc Stock’s Investor Sentiment and Interest

Search interest for Iterum Therapeutics Plc Stock has increased by 106% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:106% versus previous 30 day period

Iterum Therapeutics Plc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
2
-
-
-
-
-
-
0
Gross Profit
0
0
0
0
0
-
0
0
0
0
Operating Income
-10
-16
-11
-6
-3
-4
-3
-3
-5
-7
EBITDA
-11
-2
-11
-6
-4
-5
-5
-3
-5
-8
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-12
-3
-12
-7
-4
-5
-6
-4
-6
-8
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-12
-3
-12
-7
-4
-6
-6
-4
-6
-8
Net Profit Margin
0.00%
0.00%
-471.83%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-2302.31%

Iterum Therapeutics Plc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
0
0
0
-
-
-
-
-
Gross Profit
-
0
0
0
0
-2
-1
-1
0
Operating Income
-13
-29
-76
-102
-32
-24
-30
-47
-18
EBITDA
-13
-29
-76
-101
-36
-83
-39
-34
-21
Interest Expense
-
0
0
0
15
5
2
1
2
Depreciation
-
0
0
0
0
2
1
1
0
Income Before Tax
-13
-28
-76
-102
-51
-90
-44
-37
-24
Income Tax Expense
0
0
0
0
0
0
0
0
0
Net Income
-13
-29
-77
-103
-52
-91
-44
-38
-24
Net Profit Margin
0.00%
-5788.58%
-8867.20%
-278729.73%
0.00%
0.00%
0.00%
0.00%
0.00%

Iterum Therapeutics Plc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-3
-12
-7
-4
-6
-6
-4
-6
-8
Operating Cash Flow
-9
-12
-13
-6
-2
-4
-3
-4
-7
Investing Cash Flow
0
13
7
4
5
1
0
0
0
Financing Cash Flow
0
0
7
0
5
13
-8
5
5
Change in Cash
-8
1
1
-2
8
10
-11
0
-2

Iterum Therapeutics Plc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-29
-77
-103
-52
-91
-44
-38
-24
Operating Cash Flow
-30
-75
-81
-54
-15
-18
-39
-26
Investing Cash Flow
-31
-8
40
0
-54
13
23
18
Financing Cash Flow
45
120
2
64
83
-1
1
26
Change in Cash
-16
36
-39
9
12
-6
-15
18

Global Institutional Holdings in Iterum Therapeutics Plc

Funds
Holdings
Jane Street Group LLC
0.54%
Newbridge Financial Services Group, Inc.
0%
Alpine Partners VI, LLC
0.02%
Renaissance Technologies Corp
1.06%
Activest Wealth Management
0%
See all

Insights on Iterum Therapeutics Plc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Iterum Therapeutics Plc has experienced a drawdown of -84.3%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 81.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 11.3% return, outperforming this stock by 100.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, ITRM stock has moved down by -54.8%

About Iterum Therapeutics Plc

iterum therapeutics plc is an ireland-based clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives. these products are aimed at combatting the global crisis of multi-drug resistant (mdr) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. iterum’s first product is a novel anti-infective compound that has demonstrated potent in-vitro activity vs. a wide variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics. for more information on iterum therapeutics please visit www.iterumtx.com.
OrganisationIterum Therapeutics Plc
Headquarters3 Dublin Landings, Dublin, Ireland, D01 C4E0
IndustryHealth Technology
CEOMr. Corey N. Fishman
E-voting on sharesClick here to vote

Key Management of Iterum Therapeutics Plc

Name

Title

Dr. Michael W. Dunne M.D.

Strategic Advisor & Director

Mr. Tom Loughman Ph.D.

Senior Vice President of Technical Operations

Kevin Dalton

Senior Director of Legal Affairs & Company Secretary

Dr. Steven I. Aronin M.D.

Senior VP & Head of Clinical Development

Ms. Christine R. Coyne M.B.A.

Chief Commercial Officer

Mr. Corey N. Fishman

President, CEO & Director

FAQs

What is Iterum Therapeutics Plc share price today?

Iterum Therapeutics Plc share price today is $0.16 as on at the close of the market. Iterum Therapeutics Plc share today touched a day high of $0.17 and a low of $0.16.

What is the 52 week high and 52 week low for Iterum Therapeutics Plc share?

Iterum Therapeutics Plc share touched a 52 week high of $1.5 on and a 52 week low of $0.14 on . Iterum Therapeutics Plc stock price today i.e. is closed at $0.16,which is 89.33% down from its 52 week high and 17.91% up from its 52 week low.

What is Iterum Therapeutics Plc's market capitalisation today?

Iterum Therapeutics Plc market capitalisation is $0.00T as on .

How to invest in Iterum Therapeutics Plc Stock (ITRM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Iterum Therapeutics Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Iterum Therapeutics Plc Shares that will get you 9.3750 shares as per Iterum Therapeutics Plc share price of $0.16 per share as on March 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Iterum Therapeutics Plc Stock (ITRM) from India?

Indian investors can start investing in Iterum Therapeutics Plc (ITRM) shares with as little as ₹93.652 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹936.52 in Iterum Therapeutics Plc stock (as per the Rupee-Dollar exchange rate as on ). Based on Iterum Therapeutics Plc share’s latest price of $0.16 as on March 21, 2026 at 1:29 am IST, you will get 62.5000 shares of Iterum Therapeutics Plc. Learn more about fractional shares .

What are the returns that Iterum Therapeutics Plc has given to Indian investors in the last 5 years?

Iterum Therapeutics Plc stock has given -99.36% share price returns and 28.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?